NAP (NAPVSIPQ) is a small peptide derived from the activity-dependent neuroprotective protein (ADNP), which provides neuroprotection against amyloid-β peptide toxicity associated with Alzheimer disease. Several metal ions are able to promote the formation of amyloid-β peptide oligomers and protofibrils in human brain tissue. Although the relationship between metal ions and amyloid-β peptide peptides is extensively investigated, that with the NAP peptide is less understood. Nevertheless, our previous research revealed unexpected iron binding to NAP peptide and its analogs. However, a link between aluminum ions, Alzheimer disease and amyloid-β peptide or NAP peptides still remains controversial. Therefore, we have investigated the possible binding of aluminum ions to NAP peptide and its four analogs. Indeed, MALDI-ToF mass spectrometry (MS), including MS/MS study, and Fourier transform infrared (FT-IR) spectroscopy revealed an unexpected pattern of aluminum ion binding to both NAP peptide and its analogs. Our results have been discussed with respect to NAP protection against Alzheimer disease-related neurotoxicity.
MiuACBengaO. Aluminum and Alzheimer's disease: a new look. J Alzheimers Dis2006; 10: 179–201.
2.
MirzaAKingATroakesC, et al.Aluminium in brain tissue in familial Alzheimer's disease. J Trace Elem Med Biol2017; 40: 30–36.
3.
CesarioDFuriaEMazzoneG, et al.Complexation of Al3+ and Ni2+ by l-ascorbic acid: an experimental and theoretical investigation. J Phys Chem A2017; 121: 9773–9781.
4.
DeVotoEYokelRA. The biological speciation and toxicokinetics of aluminum. Environ Health Perspect1994; 102: 940–951.
5.
YangMHChenSCLinYF, et al.Reduction of aluminum ion neurotoxicity through a small peptide application–NAP treatment of Alzheimer's disease. J. Food Drug Anal2019; 27: 551–564.
6.
ZhengHBlatDFridkinM. Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases. J Neural Transm2006; 71: 163–172.
7.
Ashur-FabianOSegal-RuderYSkutelskyE, et al.The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide. Peptides2003; 24: 1413–1423.
8.
GozesISteingartRASpierAD. NAP mechanisms of neuroprotection. J Mol Neurosci2004; 24: 67–72.
9.
CardosoSCarvalhoCCorreiaSC, et al.Alzheimer's disease: from mitochondrial perturbations to mitochondrial medicine. Brain Pathol2016; 26: 632–647.
10.
GaggelliEKozlowskiHValensinD, et al.Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem Rev2006; 106: 1995–2044.
11.
WildburgerNCEsparzaTJLeDucRD, et al.Diversity of amyloid-beta proteoforms in the Alzheimer's disease brain. Sci Rep2017; 7: 9520.
12.
RicchelliFBuggioRDragoD, et al.Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann−Sträussler−Scheinker disease peptides in the presence of metal ions. Biochemistry2006; 45: 6724–6732.
13.
ShearerJSohPLentzS. Both Met(109) and Met(112) are utilized for Cu(II) coordination by the amyloidogenic fragment of the human prion protein at physiological pH. J Inorg Biochem2008; 102: 2103–2113.
14.
KurodaYKawaharaM. Aggregation of amyloid β-protein and its neurotoxicity: enhancement by aluminum and other metals. Tohoku J Exp Med1994; 174: 263–268.
15.
MantyhPWGhilardiJRRogersS, et al.Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J Neurochem1993; 61: 1171–1174.
16.
KawaharaMKato-NegishiM. Link between aluminum and the pathogenesis of Alzheimer's disease: the integration of the aluminum and amyloid cascade hypotheses. Int J Alzheimers Dis2011; 2011: 1–17.
17.
BondySCTruongA. Potentiation of beta-folding of β-amyloid peptide 25–35 by aluminum salts. Neurosci Lett1999; 267: 25–28.
18.
LupaescuAVSanduIPetreBA, et al.NAP neuroprotective peptide and its analogs: copper and iron binding and reduction. Rev Chim2019; 5: 1784–1790.
19.
LupaescuAVJureschiMCiobanuCI, et al.FTIR and MS evidence for heavy metal binding to anti-amyloidal NAP-like peptides. Int J Pept Res Ther2018; 25: 303–309.
20.
CiobanuCIStefanescuRNiculauaM, et al.Letter: mass spectrometric evidence for iron binding to the neuroprotective peptide NAP and its Cys5 mutant. Eur J Mass Spectrom2016; 22: 97–104.
21.
PatinyLBorelA. ChemCalc: a building block for tomorrow's chemical infrastructure. J Chem Inf Model2013; 53: 1223–1228.
22.
LupaescuAVCiobanuCIHumelnicuI, et al.Design and synthesis of new anti-amyloid nap-based/like peptides. Rev Roum Chim2019; 6: 535–546.
23.
OzSKapitanskyOIvashco-PachimaY, et al.The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins. Mol Psychiatry2014; 19: 1115–1124.
24.
ChenXDrogarisPBernM. Identification of tandem mass spectra of mixtures of isomeric peptides. J Proteome Res2010; 9: 3270–3279.
25.
OuasriARhandourADhamelincourtMC, et al.Vibrational study of (CH3)4NSbCl6 and [(CH3)4N]2SiF6. Spectrochim Acta Part A Mol Biomol Spectrosc2002; 58: 2779–2788.
26.
HanXAslanianAYatesJR. Mass spectrometry for proteomics. Curr Opin Chem Biol2008; 12: 483–490.
27.
DrochioiuGMurariuMIonL, et al.Iron and aluminum interaction with amyloid-beta peptides associated with Alzheimer's disease. AIP Conf Proc2014; 1618: 99–100.
28.
MartinRB. The chemistry of aluminum as related to biology and medicine. Clin Chem1986; 32: 1797–1806.
29.
MujikaJIRezabalEMerceroJM, et al.Aluminium in biological environments: a computational approach. Comput Struct Biotechnol J2014; 9: e201403002.
30.
GuthalsABandeiraN. Peptide identification by tandem mass spectrometry with alternate fragmentation modes. Mol Cell Proteomics2012; 11: 550–557.
31.
ChengDWangXXiY, et al.Identification of the Al-binding proteins that account for aluminum neurotoxicity and transport in vivo. Toxicol Res2018; 7: 127–135.
